BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 31029650)

  • 41. Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome.
    Whigham L; Joyce T; Harper G; Irving PM; Staudacher HM; Whelan K; Lomer MC
    J Hum Nutr Diet; 2015 Dec; 28(6):687-96. PubMed ID: 25871564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adherence to diet low in fermentable carbohydrates and traditional diet for irritable bowel syndrome.
    Clevers E; Tran M; Van Oudenhove L; Störsrud S; Böhn L; Törnblom H; Simrén M
    Nutrition; 2020 May; 73():110719. PubMed ID: 32086111
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity: A randomized crossover trial.
    Algera JP; Demir D; Törnblom H; Nybacka S; Simrén M; Störsrud S
    Clin Nutr; 2022 Dec; 41(12):2792-2800. PubMed ID: 36384081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low fermentable oligosaccharide, disaccharide, monosaccharide, and polyol diet in patients with diarrhea-predominant irritable bowel syndrome: A prospective, randomized trial.
    Goyal O; Batta S; Nohria S; Kishore H; Goyal P; Sehgal R; Sood A
    J Gastroenterol Hepatol; 2021 Aug; 36(8):2107-2115. PubMed ID: 33464683
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Food regulations: low FODMAP labeling and communication goals.
    Méance S; Giordano J; Chuang E; Schneider H
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():62-63. PubMed ID: 28244659
    [TBL] [Abstract][Full Text] [Related]  

  • 46. When the low FODMAP diet does not work.
    Halmos EP
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():69-72. PubMed ID: 28244666
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The evidence base for efficacy of the low FODMAP diet in irritable bowel syndrome: is it ready for prime time as a first-line therapy?
    Gibson PR
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():32-35. PubMed ID: 28244668
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Feasibility of Low Fermentable Oligosaccharide, Disaccharide, Monosaccharide, and Polyol Diet and Its Effects on Quality of Life in an Italian Cohort.
    Cingolani A; Paduano D; Vecchiarelli V; Demelas M; Corrias PT; Casula L; Usai P
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32182648
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of Structural Individual Low-FODMAP Dietary Advice vs. Brief Advice on a Commonly Recommended Diet on IBS Symptoms and Intestinal Gas Production.
    Patcharatrakul T; Juntrapirat A; Lakananurak N; Gonlachanvit S
    Nutrients; 2019 Nov; 11(12):. PubMed ID: 31766497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low-FODMAP Diet Is Associated With Improved Quality of Life in IBS Patients-A Prospective Observational Study.
    Kortlever TL; Ten Bokkel Huinink S; Offereins M; Hebblethwaite C; O'Brien L; Leeper J; Mulder CJJ; Barrett JS; Gearry RB
    Nutr Clin Pract; 2019 Aug; 34(4):623-630. PubMed ID: 30644587
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nutritional safety and status following a 12-week strict low FODMAP diet in patients with irritable bowel syndrome.
    Hillestad EMR; Steinsvik EK; Teige ES; Rasmussen SH; Brønstad I; Lundervold A; Hausken T; Hanevik K; Lied GA; Berentsen B
    Neurogastroenterol Motil; 2024 Jul; 36(7):e14814. PubMed ID: 38689453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Retrospective Study on Dietary FODMAP Intake in Celiac Patients Following a Gluten-Free Diet.
    Roncoroni L; Elli L; Doneda L; Bascuñán KA; Vecchi M; Morreale F; Scricciolo A; Lombardo V; Pellegrini N
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30445688
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-Fat Foods and FODMAPs Containing Gluten Foods Primarily Contribute to Symptoms of Irritable Bowel Syndrome in Korean Adults.
    Na W; Lee Y; Kim H; Kim YS; Sohn C
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33920966
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols, and quality of life in patients with irritable bowel syndrome in Colombia].
    Yepes IJ; Múnera MN; Martelo C
    Biomedica; 2018 May; 38(0):61-68. PubMed ID: 29809329
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Supplementing Dietary Fibers With a Low FODMAP Diet in Irritable Bowel Syndrome: A Randomized Controlled Crossover Trial.
    So D; Yao CK; Ardalan ZS; Thwaites PA; Kalantar-Zadeh K; Gibson PR; Muir JG
    Clin Gastroenterol Hepatol; 2022 Sep; 20(9):2112-2120.e7. PubMed ID: 34929392
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fecal Fermentation in Irritable Bowel Syndrome: Influence of Dietary Restriction of Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols.
    Valeur J; Røseth AG; Knudsen T; Malmstrøm GH; Fiennes JT; Midtvedt T; Berstad A
    Digestion; 2016; 94(1):50-6. PubMed ID: 27487397
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis.
    Marsh A; Eslick EM; Eslick GD
    Eur J Nutr; 2016 Apr; 55(3):897-906. PubMed ID: 25982757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. History of the low FODMAP diet.
    Gibson PR
    J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():5-7. PubMed ID: 28244673
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is Bacillus coagulans supplementation plus low FODMAP diet superior to low FODMAP diet in irritable bowel syndrome management?
    Abhari K; Saadati S; Hosseini-Oskouiee F; Yari Z; Hosseini H; Sohrab G; Hejazi E; Agah S; Sadeghi A; Hekmatdoost A
    Eur J Nutr; 2020 Aug; 59(5):2111-2117. PubMed ID: 31327047
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Review article: implementation of a diet low in FODMAPs for patients with irritable bowel syndrome-directions for future research.
    Mitchell H; Porter J; Gibson PR; Barrett J; Garg M
    Aliment Pharmacol Ther; 2019 Jan; 49(2):124-139. PubMed ID: 30589971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.